Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VNDA Vanda Pharmaceuticals Inc

4,77

0,01 (0,21%)

02 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Biotech Catches Major Premarket Bid Following FDA Approval

A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment...

To read the full story on AllPennyStocks.com, click here.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Vanda Pharmaceuticals Charts.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Vanda Pharmaceuticals Charts.

News Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
Dienstag 30 April 2024 (1 Tag vor) • PR Newswire (US)

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Donnerstag 25 April 2024 (7 Tage vor) • GlobeNewswire Inc.

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Dienstag 23 April 2024 (1 Woche vor) • PR Newswire (US)

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
Mittwoch 17 April 2024 (2 Wochen vor) • PR Newswire (US)

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
Mittwoch 17 April 2024 (2 Wochen vor) • PR Newswire (US)

Biotech Catches Major Premarket Bid Following FDA Approval
Mittwoch 3 April 2024 (4 Wochen vor) • AllPennyStocks.com

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
Mittwoch 3 April 2024 (4 Wochen vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Vanda Pharmaceuticals Inc News-Artikel

Euro vs US Dollar

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen